Page 34 - Pharma Sector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030.New York, May 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vials Market" - https://www.reportlinker.com/p06075957/?utm_source=GNW Due to the surging incidence of chronic and acute diseases, the pharmaceutical industry is booming. As many of the drugs are administered via injection, the expanding pharma sector is expected to propel the global vials market from $1...

Read more about Health ministry panel vetting requests by six cos to make Mucormycosis drug on Business Standard. Development come amid fast spread of disease in various states and shortage of drugs to treat it; Rajasthan has already declared an epidemic

Read more about Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic on Business Standard. The ongoing April-June quarter should see strong growth due to low base of last year

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer's permission we will charge your card/ payment instrument each month automatically and re...

The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20. Total revenue from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing. For the entire 2020-21 fiscal year, the drug maker reported a consolidated net profit of Rs 2,389 crore as against Rs 1,500 crore in the previous year. Total revenue from operations for the last fiscal year rose to Rs 19,160 crore as against Rs 17,132 crore in 2019-20. The company's board recommended a final dividend of Rs 5 per share (face value Rs 2...